Metagenome Data on Intestinal Phage-Bacteria Associations Aids the Development of Phage Therapy against Pathobionts

Kosuke Fujimoto1, Yasumasa Kimura2, Masaki Shimohigoshi3

  • 1Department of Immunology and Genomics, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan; Division of Metagenome Medicine, Human Genome Center, the Institute of Medical Sciences, the University of Tokyo, Tokyo 108-8639, Japan; Division of Innate Immune Regulation, International Research and Development Center for Mucosal Vaccines, the Institute of Medical Sciences, the University of Tokyo, Tokyo 108-8639, Japan.

Cell Host & Microbe
|July 12, 2020
PubMed

Insights

Bacteriophages (phages) show promise for eliminating gut pathogens. This study maps phage-host interactions in the human gut microbiome, aiding the development of targeted phage therapies against harmful bacteria.

Area of Science:

  • Microbiology
  • Virology
  • Genomics

Background:

  • Bacteriophages (phages) are viruses that infect bacteria and are being explored for targeted pathogen elimination.
  • Understanding phage-host interactions within the human gut microbiome is crucial for developing effective phage therapies.
  • Previous research has not fully elucidated the complex associations between phages and bacteria in the intestinal environment.

Purpose of the Study:

  • To characterize the intestinal viromes and bacteriomes in a cohort of healthy individuals.
  • To identify and map host bacteria-phage associations within the human gut.
  • To demonstrate the utility of this data for identifying phages and enzymes effective against specific pathogens like Clostridioides difficile.

Main Methods:

  • Collected fecal samples from 101 healthy Japanese individuals.
  • Performed metagenomic sequencing of both viral (viromes) and bacterial (bacteriomes) communities.
  • Analyzed genomic data to determine host bacteria-phage associations for both temperate and virulent phages.

Main Results:

  • Detailed mapping of host bacteria-phage associations in the human intestinal microbiome.
  • Identification of specific phages targeting Clostridioides difficile.
  • Validation of antibacterial enzyme activity in vitro and in vivo.

Conclusions:

  • Comprehensive metagenomic analysis provides essential insights into gut phage-host dynamics.
  • This data is vital for the development of precision phage therapies against intestinal pathobionts.
  • The study validates the potential of phage-based strategies for combating bacterial infections.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
76.9K
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
578
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.1K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
783
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
467
Genomic DNA in Prokaryotes00:46

Genomic DNA in Prokaryotes

The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
47.8K